A Phase 3, Multicenter, Double-Blind Extension Study To Evaluate Maintenance Of Efficacy Of Oral Budesonide Suspension (OBS) And Long-Term Treatment Effect Of OBS In Adolescent And Adult Subjects (11 To 55 Years Of Age, Inclusive) With Eosinophilic Esophagitis (EoE)
Principal Investigator(s)
Email for information
Funded by
GENEVA
Research Start Date
Status
Active
The Overall Study Sponsor has developed a study to Evaluate Maintenance of Efficacy of Oral Budesonide Suspension (OBS) and Long-term Treatment Effect of OBS in Adolescent and Adult Subjects (11 to 55 Years of Age, Inclusive) with Eosinophilic Esophagitis (EoE).
The appearance of name-brand products in this article does not constitute endorsement by Brooke Army Medical Center, the U.S. Army Medical Center, the U.S. Army Medical Department, the U.S. Army Office of the Surgeon General, the Department of the Army, the Department of Defense, or the U.S. Government of the information, products, or services contained therein.